Identification of micRornas regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer

Nutrition and Cancer

Volumn 65, Issue 2, 2013, Pages 247-254

  Slaby, Ondrej ^a,b   Sachlova, Milana ^a   Brezkova, Veronika ^b   Hezova, Renata ^a,b   Kovarikova, Alena ^b   Bischofová, Svatava ^a   Sevcikova, Sabina ^b   Bienertova Vasku, Julie ^b   Vasku, Anna ^b   Svoboda, Marek ^a   Vyzula, Rostislav ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

IBERIN; ISOTHIOCYANIC ACID DERIVATIVE; MICRORNA; MICRORNA 155; MICRORNA 23B; MICRORNA 27B; SULFORAPHANE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CELL CULTURE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COLORECTAL CANCER; COMPUTER MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ISOLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC REGULATION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

3' UNTRANSLATED REGIONS; AGED; BINDING SITES; CASE-CONTROL STUDIES; CELL LINE; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; DEAD-BOX RNA HELICASES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; ISOTHIOCYANATES; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTECTIVE AGENTS; RIBONUCLEASE III;

EID: 84874633536     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.756530     Document Type: Article

References (42)

1. Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, et al.: Recent trends in colorectal cancer mortality in Europe. Int J Cancer 129, 180-191, 2010.
2. Center MM, Jemal A, andWard E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18, 1688-1694, 2009.
3. Conaway CC, Yang YM, and Chung FL: Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 3, 233-255, 2002.
4. Yang Y, Yan H, Li Y, Yang ST, and Zhang X: Isothiocyanates from Broccolini seeds induce apoptosis in human colon cancer cells: proteomic and bioinformatic analyses. Pharmazie 66, 382-390, 2011.
5. Brennan P, Hsu CC, Moullan N, Szeszenia-Dabrowska N, Lissowska J, et al.: Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet 366, 1558-1560, 2005.
6. Ambrosone CB, McCann SE, Freudenheim JL,Marshall JR, Zhang Y, et al.: Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 134, 1134-1138, 2004.
7. Lin HJ, Probst-Hensch NM, Louie AD, Kau IH,Witte JS, et al.: Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 7, 647-652, 1998.
8. Hezova R, Bienertova-Vasku J, Sachlova M, Brezkova V, Vasku A, et al.: Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central-European population. Eur J Med Res 17, 17, 2012.
9. Slaby O, Svoboda M, Michalek J, and Vyzula R: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 8, 102, 2009.
10. Li Y,Kong D,Wang Z, and Sarkar FH: Regulation ofmicroRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res 27, 1027-1041, 2010.
11. Slaby O, Bienertova-Vasku J, Svoboda M, and Vyzula R: Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 16, 8-21, 2012.
12. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, and Tanzer LR: NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 32, 315-317, 1996.
13. Wang W, Wang S, Howie AF, Beckett GJ, Mithen R, et al.: Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells. J Agric Food Chem 53, 1417-1421, 2005.
14. Zeng H, Trujillo ON, Moyer MP, and Botnen JH: Prolonged sulforaphane treatment activates survival signaling in nontumorigenic NCM460 colon cells but apoptotic signaling in tumorigenic HCT116 colon cells. Nutr Cancer 63, 248-255, 2011.
15. Gong J, Tong Y, Zhang HM, Wang K, Hu T, et al.: Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 33, 254-263, 2011.
16. Friedman RC, Farh KK, Burge CB, and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105, 2009.
17. Betel D,Wilson M, GabowA,Marks DS, and Sander C: The microRNA.org resource: targets and expression. Nucleic Acids Res 36, D149-153, 2008.
18. Kruger J and Rehmsmeier M: RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34, W451-W454, 2006.
19. Hariharan M, Scaria V, and Brahmachari SK: dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 10, 108, 2009.
20. Ovesna J, Slaby O, Toussaint O, Kodicek M, Marsik P, et al.: High throughput 'omics' approaches to assess the effects of phytochemicals in human health studies. Br J Nutr 99(E Suppl 1), ES127-ES134, 2008.
21. Zhang H, Hao Y, Yang J, Zhou Y, Li J, et al.: Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2, 554, 2011.
22. Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, et al.: MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J 276, 2966-2982, 2009.
23. Castilla MA, Moreno-Bueno G, Romero-Perez L, De Vijver KV, Biscuola M, et al.:Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol 223, 72-80, 2011.
24. Yuan B, Dong R, Shi D, Zhou Y, Zhao Y, et al.: Down-regulation of miR-23b may contribute to activation of the TGF-beta1/Smad3 signalling pathway during the termination stage of liver regeneration. FEBS Lett 585, 927-934, 2011.
25. Lee JJ, Drakaki A, Iliopoulos D, Struhl K: MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene 31, 3818-3825, 2012.
26. Faraoni I, Antonetti FR, Cardone J, Bonmassar E: miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792, 497-505, 2009.
27. Tili E, Croce CM, and Michaille JJ: miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 28, 264-284, 2009.
28. Bakirtzi K, Hatziapostolou M, Karagiannides I, Polytarchou C, Jaeger S, et al.: Neurotensin signaling activates microRNAs-21 and-155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors. Gastroenterology 141, 1749-1761, 2011.
29. Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T: Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 79, 313-320, 2011.
30. Tili E, Michaille JJ, Adair B, Alder H, Limagne E, et al.: Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 31, 1561-1566, 2010.
31. Xi B, Zeng T, Liu L, Liang Y, Liu W, et al.: Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 130, 561-568, 2011.
32. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, et al.: Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3-untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81, 405-413, 2007.
33. Liu Z, Wei S, Ma H, Zhao M, Myers JN, et al.: A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 32, 1668-1674, 2011.
34. Spindler KL, Lindebjerg J, Lahn M, Kjaer-Frifeldt S, and Jakobsen A: Protein kinase C-beta II (PKC-beta II) expression in patients with colorectal cancer. Int J Colorectal Dis 24, 641-645, 2009.
35. Zhu X, Wang F, Lin MC, Tian L, Fan W, et al.: The 3-UTR variants in the GRP78 are not associated with overall survival in resectable hepatocellular carcinoma. PLoS One 6, e17783, 2011.
36. Chiosea S, Acquafondata M, Luo J, Kuan S, and Seethala R: DICER1 and PRKRA in Colon Adenocarcinoma. Biomark Insights 3, 253-258, 2008.
37. Papachristou DJ, Korpetinou A, Giannopoulou E, Antonacopoulou AG, Papadaki H, et al.: Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch 459, 431-440, 2011.
38. Faber C, Horst D, Hlubek F, and Kirchner T: Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 47, 1414-1419, 2008.
39. Stratmann J, Wang CJ, Gnosa S, Wallin A, Hinselwood D, et al.: Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 11, 345, 2011.
40. Akhtar N, Rasheed Z, Ramamurthy S, Anbazhagan AN, Voss FR, et al.: MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 62, 1361-1371, 2010.
41. Chinchilla A, Lozano E, Daimi H, Esteban FJ, Crist C, et al.: MicroRNA profiling duringmouse ventricular maturation: a role for miR-27 modulating Mef2c expression. Cardiovasc Res 89, 98-108, 2010.
42. Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, et al.: miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29, 4914-4924, 2010.